Aggressive inherited and sporadic medullary thyroid carcinomas display similar oncogenic pathways

Endocrine-Related Cancer

Volumn 16, Issue 4, 2009, Pages 1261-1272

  Ameur, Nabahet ^a   Lacroix, Ludovic ^a   Roucan, Sophie ^a   Roux, Véronique ^a   Broutin, Sophie ^a   Talbot, Monique ^a   Dupuy, Corinne ^a   Caillou, Bernard ^a   Schlumberger, Martin ^a   Bidart, Jean Michel ^a  

^a INSTITUT GUSTAVE ROUSSY   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CARCINOEMBRYONIC ANTIGEN RELATED CELL ADHESION MOLECULE 6; CELL ADHESION MOLECULE; COLLAGEN TYPE 1; COLLAGEN TYPE 1A1; COLLAGEN TYPE 1A2; PLEIOTROPHIN; PROTEIN ESM1; SEPRASE; SMALL INTERFERING RNA; TRANSCRIPTOME; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGED; ARTICLE; BONE METASTASIS; BRAIN METASTASIS; CANCER INVASION; CANCER STAGING; CELL PROLIFERATION; CHILD; CLINICAL ARTICLE; DISTANT METASTASIS; DNA MICROARRAY; DOWN REGULATION; FEMALE; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE OVEREXPRESSION; GENE SEQUENCE; GENE SILENCING; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INHERITANCE; LIVER METASTASIS; LUNG METASTASIS; LYMPH NODE METASTASIS; MALE; MEDULLARY CARCINOMA; MULTIPLE ENDOCRINE NEOPLASIA; NECK METASTASIS; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; THYROID CARCINOMA; UPREGULATION;

ADOLESCENT; ADULT; AGED; CARCINOMA, MEDULLARY; CHILD; CHILD, PRESCHOOL; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOENZYME TECHNIQUES; MALE; MIDDLE AGED; MUTATION; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; ONCOGENES; PROGNOSIS; PROTO-ONCOGENE PROTEINS C-RET; RNA, SMALL INTERFERING; THYROID NEOPLASMS; TUMOR MARKERS, BIOLOGICAL; YOUNG ADULT;

EID: 72549114451     PISSN: 13510088     EISSN: 14796821     Source Type: Journal    
DOI: 10.1677/ERC-08-0289     Document Type: Article

References (33)

1. Bachelot A, Lombardo F, Baudin E, Bidart JM & Schlumberger M 2002 Inheritable forms of medullary thyroid carcinoma. Biochimie 84 61-66. (Pubitemid 34477093)
2. Ball D 2007 Medullary thyroid cancer: monitoring and therapy. Endocrinology and Metabolism Clinics of North America 36 823-837. (Pubitemid 47126253)
3. Barbosa SL, Rodien P, Leboulleux S, Niccoli-Sire P, Kraimps JL, Caron P, Archambeaud-Mouveroux F, Conte-Devolx B, Rohmer V & Groupe d' Etude des Tumeurs Endocrines 2005 Ectopic adrenocorticotropic hormone-syndrome in medullary carcinoma of the thyroid: a retrospective analysis and review of the literature. Thyroid 15 618-623.
4. Chang Y, Zuka M, Perez-Pinera P, Astudillo A, Mortimer J, Berenson JR & Deuel TF 2007 Secretion of pleiotrophin stimulates breast cancer progression through remodelling of the tumor microenvironment. PNAS 104 10888-10893. (Pubitemid 47175196)
5. Donis-Keller H, Dou S, Chi D, Carlson KM, Toshima K, Lairmore TC, Howe JR, Moley JF, Goodfellow P & Wells SA 1993 Mutations in the RET proto-oncogene are associated with MEN 2A and FMTC. Human Molecular Genetics 2 851-856. (Pubitemid 23216611)
6. Gujral TS, van Veelen W, Richardson DS, Myers SM, Meens JA, Acton DS, Duñach M, Elliott BE, Höppener JW & Mulligan LM 2008 A novel RET kinase-beta-catenin signaling pathway contributes to tumorigenesis in thyroid carcinoma. Cancer Research 68 1338-1346.
7. Hennige AM, Lammers R, Arlt D, Höppner W, Strack V, Niederfellner G, Seif FJ, Häring HU & Kellerer M 2000 Ret oncogene signal transduction via a IRS-2/PI 3-kinase/PKB and a SHC/Grb-2 dependent pathway: possible implication for transforming activity in NIH3T3 cells. Molecular and Cellular Endocrinology 167 69-76. (Pubitemid 30734787)
8. Hoff AO & Hoff PM 2007 Medullary thyroid carcinoma. Hematology/Oncology Clinics of North America 21 475-488.
9. Jain S, Watson MA, DeBenedetti MK, Hiraki Y, Moley JF & Milbrandt J 2004 Expression profiles provide insights into early malignant potential and skeletal abnormalities in multiple endocrine neoplasia type 2B syndrome tumors. Cancer Research 64 3907-3913. (Pubitemid 38697303)
10. Kadomatsu K & Muramatsu T 2004 Midkine and pleiotrophin in neural development and cancer. Cancer Letters 204 127-143. (Pubitemid 38167717)
11. Klomp HJ, Zernial O, Flachmann S, Wellstein A & Juhl H 2002 Significance of the expression of the growth factor pleiotrophin in pancreatic cancer patients. Clinical Cancer Research 8 823-827. (Pubitemid 34742114)
12. Kurokawa K, Kawai K, Hashimoto M, Ito Y & Takahashi M 2003 Cell signalling and gene expression mediated by RET tyrosine kinase. Journal of Internal Medicine 253 627-633. (Pubitemid 36649094)
13. Lacroix L, Lazar V, Michiels S, Ripoche H, Dessen P, Talbot M, Caillou B, Levillain JP, Schlumberger M & Bidart JM 2005 Follicular thyroid tumors with the PAX8-PPARgamma1 rearrangement display characteristic genetic alterations. American Journal of Pathology 167 223-231. (Pubitemid 40884783)
14. Leboulleux S, Baudin E, Travagli JP & Schlumberger M 2004 Medullary thyroid carcinoma. Clinical Endocrinology 61 299-310.
15. Malerczyk C, Schulte AM, Czubayko F, Bellon L, Macejak D, Riegel AT & Wellstein A 2005 Ribozyme targeting of the growth factor pleiotrophin in established tumors: a gene therapy approach. Gene Therapy 12 339-346. (Pubitemid 40310136)
16. Manie S, Santoro M, Fusco A & Billaud M 2001 The RET receptor: function in development and dysfunction in congenital malformation. Trends in Genetics 17 580-589. (Pubitemid 32918300)
17. Matias-Guiu X, DeLellis R, Moley JF, Gagel RF, Albores-Saavedra J, Bussolati G, Kaserer K, Williams ED & Baloch Z 2004 Medullary thyroid carcinoma. In Pathology and Genetics: Tumours of Endocrine Organs, World Health Orgnization Classification of Tumours, pp 86-91. Lyon: IARC Library.
18. Meng K, Rodriguez-Peña A, Dimitrov T, Chen W, Yamin M, Noda M & Deuel TF 2000 Pleiotrophin signals increased tyrosine phosphorylation of beta beta-catenin through inactivation of the intrinsic catalytic activity of the receptor-type protein tyrosine phosphatase beta/zeta. PNAS 97 2603-2608. (Pubitemid 30159217)
19. Musholt TJ, Hanack J, Brehm C, von Wasielewski R & Musholt PB 2005 Searching for non-RET molecular alterations in medullary thyroid carcinoma: expression analysis by mRNA differential display. World Journal of Surgery 29 472-482. (Pubitemid 41125372)
20. Oue N, Hamai Y, Mitani Y, Matsumura S, Oshimo Y, Aung PP, Kuraoka K, Nakayama H & Yasui W 2004 Gene expression profile of gastric carcinoma: identification of genes and tags potentially involved in invasion, metastasis, and carcinogenesis by serial analysis of gene expression. Cancer Research 64 2397-2405. (Pubitemid 38523892)
21. Panta GR, Nwariaku F & Kim LT 2004 RET signals through focal adhesion kinase in medullary thyroid cancer cells. Surgery 136 1212-1217. (Pubitemid 39647536)
22. Plaza Menacho I, Koster R, van der Sloot AM, Quax WJ, Osinga J, van der Sluis T, Hollema H, Burzynski GM, Gimm O, Buys CH et al. 2005 RET-familial medullary thyroid carcinoma mutants Y791F and S891A activate a Src/JAK/STAT3 pathway, independent of glial cell line-derived neurotrophic factor. Cancer Research 65 1729-1737. (Pubitemid 40478598)
23. Ponder BA 1999 The phenotypes associated with ret mutations in the multiple endocrine neoplasia type 2 syndrome. Cancer Research 59 1736s-1741s.
24. Russo D, Arturi F, Pontecorvi A & Filetti S 1999 Genetic analysis in fine-needle aspiration of the thyroid: a new tool for the clinic. Trends in Endocrinology and Metabolism 10 280-285. (Pubitemid 29403734)
25. Santoro M, Melillo RM, Carlomagno F, Vecchio G & Fusco A 2004 RET: normal and abnormal functions. Endocrinology 145 5448-5451.
26. Sariola H & Saarma M 2003 Novel functions and signalling pathways for GDNF. Journal of Cell Science 116 3855-3862. (Pubitemid 37279301)
27. Schlumberger M, Carlomagno F, Baudin E, Bidart JM & Santoro M 2008 New therapeutic approaches to treat medullary thyroid carcinoma. Nature Clinical Practice. Endocrinology and Metabolism 4 22-32. (Pubitemid 350291115)
28. Shibata Y, Tsukazaki T, Hirata K, Xin C & Yamaguchi A 2004 Role of a new member of IGFBP superfamily, IGFBP-rP10, in proliferation and differentiation of osteoblastic cells. Biochemical and Biophysical Research Communications 325 1194-1200. (Pubitemid 39535889)
29. Smallridge RC, Bourne K, Pearson BW, Van Heerden JA, Carpenter PC & Young WF 2003 Cushing's syndrome due to medullary thyroid carcinoma: diagnosis by proopiomelanocortin messenger ribonucleic acid in situ hybridization. Journal of Clinical Endocrinology and Metabolism 88 4565-4568. (Pubitemid 37357494)
30. Thomas S, Chiriva-Internati M & Shah GV 2007 Calcitonin receptor-stimulated migration of prostate cancer cells is mediated by urokinase receptor-integrin signaling. Clinical & Experimental Metastasis 24 363-377. (Pubitemid 47134743)
31. Wary KK, Mariotti A, Zurzolo C & Giancotti FG 1998 A requirement for caveolin-1 and associated kinase Fyn in integrin signaling and anchorage-dependent cell growth. Cell 94 625-634. (Pubitemid 28427581)
32. Watanabe T, Ichihara M, Hashimoto M, Shimono K, Shimoyama Y, Nagasaka T, Murakumo Y, Murakami H, Sugiura H, Iwata H et al. 2002 Characterization of gene expression induced by RET with MEN2A or MEN2B mutation. American Journal of Pathology 161 249-256. (Pubitemid 34760790)
33. Zabel M & Grzeszkowiak J 1997 Characterisation of thyroid medullary carcinoma TT cell line. Histology and Histopathology 12 283-289. (Pubitemid 27106938)